Sayeeda MUSSAVIRA, Mala DHARMALINGAM, Bindhu Omana SUKUMARAN

Salivary glucose and antioxidant defense markers in type II diabetes mellitus

To evaluate salivary antioxidant defense markers, their correlation with salivary glucose, and glycemic status in type II diabetes mellitus (DM). Materials and methods: The study included 53 diabetic patients and 40 healthy subjects. Salivary glucose, blood glucose, and uric acid (UA) were determined by specific enzymatic methods. Total antioxidant activity (AOA), glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), and total protein were determined spectrophotometrically. Results: Salivary UA (3.12 vs. 1.89 mg/dL), GSH (47 vs. 11.92 µg/mL), and total protein (375.12 vs. 202.23 mg/dL) were significantly higher (P < 0.001; r = 0.455, 0.735, 0.498 respectively) and AOA (653.1 vs. 897.3 µmol/L) was significantly lower in the DM group (P < 0.001, r = -0.431) compared to healthy controls. Among the antioxidant enzymes, CAT was significantly lower (1214 vs. 9468.9 kat) in the DM group (P < 0.001, r = -0.886). Spearman correlation analyses within the diabetic group showed a strong positive association between salivary glucose and blood glucose (P < 0.001, r = 0.9), salivary glucose and GSH, and salivary glucose and UA. Salivary glucose showed a negative correlation with AOA and CAT (P = 0.008, r = -0.447) in the diabetic group. Conclusion: Findings of this study, showing a strong correlation between salivary glucose and blood glucose as well as changes in antioxidant components in the DM group, suggest that saliva can be used for the diagnosis and management of DM.

Anahtar Kelimeler:

Antioxidant activity, catalase, diabetes mellitus, glutathione, oxidative stress, saliva, superoxide dismutase, uric acid

Salivary glucose and antioxidant defense markers in type II diabetes mellitus

Keywords:

Antioxidant activity, catalase, diabetes mellitus, glutathione, oxidative stress, saliva, superoxide dismutase, uric acid,

PDF

___

Scully T. Diabetes in numbers. Nature 2012; 485: S2–S3.
Ben-Aryeh H, Serouya R, Kanter Y, Szargel R, Laufer D. Salivary composition in diabetic patients. J Diabetes Complicat 1988; 2: 96–99. 3. Pfaffe T, Cooper-White J, Kostner K, Punyadeera C. Diagnostic potential of saliva: current state and future applications. Clin Chem 2011; 57: 675–687.
Mealey B. Diabetes mellitus. In: Greenberg MS, Glick M, editors. Burket’s Oral Medicine. 10th ed. Hamilton, ON, Canada: BC Decker Inc.; 2003. pp. 5–33.
Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998; 44: 1309–1315. 9. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54: 356–361.
Pisoschi AM, Negulescu GP. Methods for total antioxidant activity determination: a review. Biochemistry & Analytical Biochemistry 2011; 1: 1000106.
Panchbhai AS, Degwekar, Shirish S, Bhowte RR. Estimation of salivary glucose amylase and salivary flow rate in diabetes in India. J Oral Sci 2010; 52: 359–368.
Aydin S. A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics. J Biochem Mol Biol 2007; 40: 29–35.
Scott DA, Renaud DE, Krishnasamy S, Meriç P, Buduneli N, Çetinkalp Ş, Liu KZ. Diabetes-related molecular signatures in infrared spectra of human saliva. Diabetol Metab Syndr 2010; 2: 1–9.
Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389–394.
Kakkar P, Das B, Vishwanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Bio 1984; 21: 130–132.
Khan H, Jan SU, Hasmatullah, Khan FM, Khan AM, Rehman AUR, Abdul W. Effect of lithium metal on the chemical status of glutathione (GSH) present in whole blood (especially in plasma and cytosolic fraction in human blood). Pak J Pharm Sci 2010; 23: 188–193.
Al-Rawi HN. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res 2011; 8: 22–28.
Hegde A, Shenoy R, D’Mello P, A Smitha, Tintu A, Manjrekar P. Alternative markers of glycemic status in diabetes mellitus. Biomed Res 2010; 21: 7–9.
Carda C, Mosquera-Lloreda N, Salom L, Gomez de Ferraris ME, Peydró A. Structural and functional salivary disorders in type 2 diabetic patients. Med Oral Patol Oral 2006; 11: E309– E314.
Jurysta C, Bulur N, Oguzhan B, Satman I, Yilmaz TM, Malaisse WJ, Sener A. Salivary glucose concentration and excretion in normal and diabetic subjects. J Biomed Biotechnol 2009; 2009: 430426.
Chávez EM, Borrell LN, Taylor GW, Ship JA. A longitudinal analysis of salivary flow in control subjects and older adults with type 2 diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 166–173.
Nogueira FN, Carvalho AM, Yamaquti PM, Nicolau J. Antioxidant parameters and lipid peroxidation in salivary glands of streptozotocin-induced diabetic rats. Clin Chim Acta 2005; 353: 133–139.
Ibuki FK, Simões A, Nogueira FN. Antioxidant enzymatic defense in salivary glands of streptozotocin-induced diabetic rats: a temporal study. Cell Biochem Funct 2010; 28: 503–508.
Leite MF, Lima AM, Massuyama MM, Otto R. Astaxanthin restores the enzymatic antioxidant profile in salivary gland of alloxan-induced diabetic rats. Arch Oral Biol 2010; 55: 479– 485.
Sautin YY, Johnson RJ. Uric acid: the oxidant–antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 2008; 27: 608–619.
Soukup M, Biesiada I, Henderson A, Idowu B, Rodeback D, Ridpath L, Bridges EG, Nazar AM, Bridges KG. Salivary uric acid as a noninvasive biomarker of metabolic syndrome. Diabetol Metab Syndr 2012; 4: 14.
Savu O, Ionescu-Trigoviste C, Atanasu V, Gaman L, Papacocea R, Stoian I. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J Int Med Res 2012; 40: 709–716.
Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxide in type II diabetes mellitus. Cell Biochem Funct 2003; 21: 291–296.
Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani MJ, Larijani B, Abdollahi M. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 2005; 36: 376–381.
Dodds MW, Dodds AP. Effects of glycemic control on saliva flow rates and protein composition in non-insulin-dependent diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 465–470.
Dwivedi J, Sarka PD. Oxidative stress with homocysteine, lipoprotein (a) and lipid profile in diabetic nephropathy. Int J Appl Biol Pharm Technol 2010; 1: 840–846.